These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33249279)

  • 1. Retraction Notice to "Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells of hepatocellular carcinoma HepG2 cells" [Biomedicine & Pharmacotherapy 83 (2016) 372-380].
    Wang Q; Wang Y; Xing Y; Yan Y; Guo P; Zhuang J; Qin F; Zhang J
    Biomed Pharmacother; 2021 Jan; 133():110882. PubMed ID: 33249279
    [No Abstract]   [Full Text] [Related]  

  • 2. RETRACTED: Physcion 8-O-β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells.
    Wang Q; Wang Y; Xing Y; Yan Y; Guo P; Zhuang J; Qin F; Zhang J
    Biomed Pharmacother; 2016 Oct; 83():372-380. PubMed ID: 27416558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction Notice to "Upregulation of miR-124 by physcion 8-O-β-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76" [Biomedicine & Pharmacotherapy 84 (2016) 166-176].
    Zhang D; Yantao H; Xu L
    Biomed Pharmacother; 2021 Jan; 133():110881. PubMed ID: 33248406
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Physcion 8-O-β-glucopyranoside suppresses tumor growth of Hepatocellular carcinoma by downregulating PIM1" [Biomed. Pharmacother. 92 (2017) 451-458].
    Wang Q; Jiang Y; Guo R; Lv R; Liu T; Wei H; Ming H; Tian X
    Biomed Pharmacother; 2022 Feb; 146():112625. PubMed ID: 35031233
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis" [Biomed. Pharmacother. 104 (2018) 28-35].
    Wang Q; Yi Y; Zhang J; Guo P; Xing Y; Wang Y; Qin F; Zeng Q
    Biomed Pharmacother; 2021 Feb; 134():111070. PubMed ID: 33383313
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
    Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane inhibits TGF-β-induced epithelial-mesenchymal transition of hepatocellular carcinoma cells via the reactive oxygen species-dependent pathway.
    Wu J; Han J; Hou B; Deng C; Wu H; Shen L
    Oncol Rep; 2016 May; 35(5):2977-83. PubMed ID: 26935987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment.
    Cao X; Xu L; Liu Q; Yang L; Li N; Li X
    Oncol Res; 2019 Feb; 27(3):301-309. PubMed ID: 29562958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physcion induces apoptosis in hepatocellular carcinoma by modulating miR-370.
    Pan X; Wang H; Tong D; Wang C; Sun L; Zhao C; Li Y; Zhu L; Wu D
    Am J Cancer Res; 2016; 6(12):2919-2931. PubMed ID: 28042511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCRP1 inhibits TGF-β induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang W; Wang JG; Xu J; Zhou D; Ren K; Hou C; Chen L; Liu X
    Int J Oncol; 2017 Apr; 50(4):1233-1240. PubMed ID: 28350062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.
    Dong S; Kong J; Kong F; Kong J; Gao J; Ji L; Pan B; Chen L; Zheng L; Sun W
    BMC Cancer; 2015 Nov; 15():939. PubMed ID: 26620566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
    Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of the
    Zhang J; Ma H; Yang L; Yang H; He Z
    J Int Med Res; 2019 Mar; 47(3):1319-1329. PubMed ID: 30678511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction notice to "Protective autophagy induced by physcion suppresses hepatocellular carcinoma cell metastasis by inactivating the JAK2/STAT3 Axis" [Life Sci. 214 (2018) 124-135].
    Pan X; Wang C; Li Y; Zhu L; Zhang T
    Life Sci; 2020 Aug; 254():117789. PubMed ID: 32482465
    [No Abstract]   [Full Text] [Related]  

  • 16. Twist1-related miR-26b-5p suppresses epithelial-mesenchymal transition, migration and invasion by targeting SMAD1 in hepatocellular carcinoma.
    Wang Y; Sun B; Zhao X; Zhao N; Sun R; Zhu D; Zhang Y; Li Y; Gu Q; Dong X; Wang M; An J
    Oncotarget; 2016 Apr; 7(17):24383-401. PubMed ID: 27027434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exploration research on hepatotoxic constituents from Polygonum multiflorum root].
    Yang M; Liu T; Feng WH; Hui LQ; Li RR; Liu XQ; Chen AJ; Li C; Wang ZM
    Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1289-1296. PubMed ID: 28879745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinobufotalin inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells through down-regulate β-catenin in vitro and in vivo.
    Li W; Pei S; Zhang X; Qi D; Zhang W; Dou Y; Yang R; Yao X; Zhang Z; Xie S; Fang D; Sun H
    Eur J Pharmacol; 2022 May; 922():174886. PubMed ID: 35292248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
    Sun L; Li PB; Yao YF; Xiu AY; Peng Z; Bai YH; Gao YJ
    World J Gastroenterol; 2018 Mar; 24(10):1120-1133. PubMed ID: 29563756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition.
    Li J; Yang B; Zhou Q; Wu Y; Shang D; Guo Y; Song Z; Zheng Q; Xiong J
    Carcinogenesis; 2013 Jun; 34(6):1343-51. PubMed ID: 23430956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.